Skip to main content
Premium Trial:

Request an Annual Quote

ABI Shares Up 13 Percent as Fiscal Q1 Revenue Surges

NEW YORK (GenomeWeb News) — Shares in Applied Biosystems were up 13.04 percent, or $4.40, at $37.91 in mid-afternoon trading today after the company said fiscal first quarter revenues increased 15 percent.
 
Separately today, investment bank UBS upgraded ABI’s stock to ‘Neutral’ from ‘Reduce.’
 
As GenomeWeb News reported today, ABI reported that for the three months ended Sept. 30 total sales increased to $476.3 million from $415.5 million last year
 
ABI said that sequencing revenue increased 5.2 percent to $131.5 million from $124.9 million in the year ago period; RT-PCR sales increased 30 percent to $158.1 million; mass spec sales increase 19 percent in the period to $116 million; core PCR and DNA synthesis declined 3 percent to $46.2 million; and “other” products increased 1 percent to $24.5 million.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.